Literature DB >> 19122126

Psychosocial issues in hepatitis C: a qualitative analysis.

E Amy Janke1, Sarah McGraw, Guadalupe Garcia-Tsao, Liana Fraenkel.   

Abstract

BACKGROUND: Despite demonstrated prevalence of psychosocial problems among hepatitis C (HCV) patients, little is known about how these problems develop, why they are sustained, and how clinical providers can effectively intervene.
OBJECTIVE: The authors used a qualitative approach to investigate the nature of psychosocial issues in HCV.
METHOD: Focus groups were conducted with HCV patients.
RESULTS: Participants discussed significant feelings of anger, depression, and stigma associated with the diagnosis and noted that these feelings/experiences isolated them from potential sources of social support.
CONCLUSION: Results have important implications for clinical providers and suggest pathways by which HCV-related psychosocial factors may interact with and affect quality of life.

Entities:  

Mesh:

Year:  2008        PMID: 19122126      PMCID: PMC2743862          DOI: 10.1176/appi.psy.49.6.494

Source DB:  PubMed          Journal:  Psychosomatics        ISSN: 0033-3182            Impact factor:   2.386


  22 in total

1.  Safety of the treatment of interferon-alpha-induced depression.

Authors:  Jennifer M Loftis; Peter Hauser
Journal:  Psychosomatics       Date:  2003 Nov-Dec       Impact factor: 2.386

2.  The prevalence of hepatitis C virus infection in the United States, 1988 through 1994.

Authors:  M J Alter; D Kruszon-Moran; O V Nainan; G M McQuillan; F Gao; L A Moyer; R A Kaslow; H S Margolis
Journal:  N Engl J Med       Date:  1999-08-19       Impact factor: 91.245

3.  Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy. The Consensus Interferon Study Group.

Authors:  H L Bonkovsky; J M Woolley
Journal:  Hepatology       Date:  1999-01       Impact factor: 17.425

4.  Emotional distress in chronic hepatitis C patients not receiving antiviral therapy.

Authors:  Robert J Fontana; Khozema B Hussain; Steven M Schwartz; Cheryl A Moyer; Grace L Su; Anna S F Lok
Journal:  J Hepatol       Date:  2002-03       Impact factor: 25.083

5.  Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Centers for Disease Control and Prevention.

Authors: 
Journal:  MMWR Recomm Rep       Date:  1998-10-16

6.  Hepatitis C virus-infected patients report communication problems with physicians.

Authors:  Susan Zickmund; Stephen L Hillis; Mitchell J Barnett; Laura Ippolito; Douglas R LaBrecque
Journal:  Hepatology       Date:  2004-04       Impact factor: 17.425

Review 7.  NIH Consensus Statement on Management of Hepatitis C: 2002.

Authors: 
Journal:  NIH Consens State Sci Statements       Date:  2002 Jun 10-12

8.  Psychiatric symptoms in patients with chronic hepatitis C receiving interferon alfa-2b therapy.

Authors:  Michael R Kraus; Arne Schäfer; Hermann Faller; Herbert Csef; Michael Scheurlen
Journal:  J Clin Psychiatry       Date:  2003-06       Impact factor: 4.384

9.  Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group.

Authors:  J G McHutchison; S C Gordon; E R Schiff; M L Shiffman; W M Lee; V K Rustgi; Z D Goodman; M H Ling; S Cort; J K Albrecht
Journal:  N Engl J Med       Date:  1998-11-19       Impact factor: 91.245

10.  "They treated me like a leper". Stigmatization and the quality of life of patients with hepatitis C.

Authors:  Susan Zickmund; Evelyn Y Ho; Masahiro Masuda; Laura Ippolito; Douglas R LaBrecque
Journal:  J Gen Intern Med       Date:  2003-10       Impact factor: 5.128

View more
  13 in total

1.  Improving support and education of low-income baby boomers diagnosed with chronic hepatitis C virus infection through universal screening.

Authors:  Barbara J Turner; Kathryn Craig; Vidhi S Makanji; Bertha E Flores; Ludivina Hernandez
Journal:  J Clin Nurs       Date:  2017-05-23       Impact factor: 3.036

2.  Social support and clinical outcomes during antiviral therapy for chronic hepatitis C.

Authors:  Donna M Evon; Denise A Esserman; Darmendra Ramcharran; Jason E Bonner; Michael W Fried
Journal:  J Psychosom Res       Date:  2011-06-30       Impact factor: 3.006

Review 3.  Review of patient-reported outcome measures in chronic hepatitis C.

Authors:  Leah Kleinman; Sally Mannix; Yong Yuan; Shannon Kummer; Gilbert L'Italien; Dennis Revicki
Journal:  Health Qual Life Outcomes       Date:  2012-08-07       Impact factor: 3.186

Review 4.  Hepatitis C in HIV-infected individuals: cure and control, right now.

Authors:  David L Thomas; Dennis Leoutsakas; Tomas Zabransky; M Suresh Kumar
Journal:  J Int AIDS Soc       Date:  2011-05-08       Impact factor: 5.396

5.  Knowledge of HBV and HCV and individuals' attitudes toward HBV- and HCV-infected colleagues: a national cross-sectional study among a working population in Japan.

Authors:  Hisashi Eguchi; Koji Wada
Journal:  PLoS One       Date:  2013-09-26       Impact factor: 3.240

Review 6.  Systematic review: unmet supportive care needs in people diagnosed with chronic liver disease.

Authors:  Patricia C Valery; Elizabeth Powell; Neta Moses; Michael L Volk; Steven M McPhail; Paul J Clark; Jennifer Martin
Journal:  BMJ Open       Date:  2015-04-08       Impact factor: 2.692

7.  Hepatitis C and Social Work.

Authors:  Heather Mack; Ian Paylor
Journal:  Br J Soc Work       Date:  2014-03-04

8.  The International development of PROQOL-HCV: An instrument to assess the health-related quality of life of patients treated for Hepatitis C virus.

Authors:  Andrew Richard Armstrong; Susan Elizabeth Herrmann; Olivier Chassany; Christophe Lalanne; Mariliza Henrique Da Silva; Eliana Galano; Patrizia M Carrieri; Vincent Estellon; Philippe Sogni; Martin Duracinsky
Journal:  BMC Infect Dis       Date:  2016-08-23       Impact factor: 3.090

Review 9.  Patient capacity and constraints in the experience of chronic disease: a qualitative systematic review and thematic synthesis.

Authors:  Kasey R Boehmer; Michael R Gionfriddo; Rene Rodriguez-Gutierrez; Abd Moain Abu Dabrh; Aaron L Leppin; Ian Hargraves; Carl R May; Nathan D Shippee; Ana Castaneda-Guarderas; Claudia Zeballos Palacios; Pavithra Bora; Patricia Erwin; Victor M Montori
Journal:  BMC Fam Pract       Date:  2016-09-01       Impact factor: 2.497

Review 10.  The ongoing impacts of hepatitis c--a systematic narrative review of the literature.

Authors:  Emma R Miller; Stephen McNally; Jack Wallace; Marisa Schlichthorst
Journal:  BMC Public Health       Date:  2012-08-18       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.